Oragenics Debt to Equity Ratio 2006-2018 | OGEN

Current and historical debt to equity ratio values for Oragenics (OGEN) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Oragenics debt/equity for the three months ending June 30, 2018 was 0.00.
Oragenics Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2018-06-30 $0.00B $-0.00B 0.00
2018-03-31 $0.00B $-0.00B 0.00
2017-12-31 $0.00B $0.00B 0.00
2017-09-30 $0.00B $0.00B -10.32
2017-06-30 $0.00B $0.00B 103.00
2017-03-31 $0.00B $0.00B 0.00
2016-12-31 $0.00B $0.00B 0.00
2016-09-30 $0.00B $0.00B 0.00
2016-06-30 $0.00B $0.01B 0.00
2016-03-31 $0.00B $0.00B 0.00
2015-12-31 $0.00B $0.01B 0.00
2015-09-30 $0.00B $0.00B 0.00
2015-06-30 $0.00B $0.00B 0.00
2015-03-31 $0.00B $0.01B 0.00
2014-12-31 $0.00B $0.01B 0.00
2014-09-30 $0.00B $0.01B 0.00
2014-06-30 $0.00B $0.01B 0.00
2014-03-31 $0.00B $0.01B 0.00
2013-12-31 $0.00B $0.02B 0.00
2013-09-30 $0.00B $0.00B 0.00
2013-06-30 $0.00B $0.01B 0.00
2013-03-31 $0.00B $0.01B 0.00
2012-12-31 $0.00B $0.01B 0.00
2012-09-30 $0.00B $0.01B 0.00
2012-06-30 $0.00B $-0.00B -1.42
2012-03-31 $0.00B $0.00B -2.46
2011-12-31 $0.00B $-0.01B 0.00
2011-09-30 $0.00B $-0.01B 0.00
2011-06-30 $0.01B $-0.01B -0.90
2011-03-31 $0.00B $-0.00B -0.90
2010-12-31 $0.00B $-0.00B -1.05
2010-09-30 $0.00B $0.00B 0.00
2010-06-30 $0.00B $0.00B 0.00
2010-03-31 $0.00B $0.00B 0.00
2009-12-31 $0.00B $0.00B 0.00
2009-09-30 $0.00B $-0.00B -1.12
2009-06-30 $0.00B $-0.00B -0.78
2009-03-31 $0.00B $-0.00B 0.00
2008-12-31 $0.00B $0.00B 0.00
2008-09-30 $0.00B $0.00B 0.00
2008-06-30 $0.00B $0.00B 0.00
2008-03-31 $0.00B $0.00B 0.00
2007-12-31 $0.00B $0.00B 0.00
2007-09-30 $0.00B $0.00B 0.00
2007-06-30 $0.00B $0.00B 0.00
2007-03-31 $0.00B $0.00B 0.00
2006-12-31 $0.00B $0.00B 0.00
2006-09-30 $0.00B $0.00B 0.00
2006-06-30 $0.00B $0.00B 0.00
2006-03-31 $0.00B $0.00B 0.00
2005-12-31 $0.00B $0.00B 0.00
2005-09-30 $0.00B $0.00B 0.00
2005-06-30 $0.00B $0.00B 0.16
2005-03-31 $0.00B $0.00B 0.12
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.015B $0.001B
Oragenics Inc is a biotechnology company focused on the development and licensure of innovative products and technologies for improving human health.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $131.247B 15.06
Gilead Sciences (GILD) United States $98.029B 10.88
Biogen (BIIB) United States $68.134B 14.44
Celgene (CELG) United States $59.279B 11.84
Illumina (ILMN) United States $48.357B 60.58
Vertex Pharmaceuticals (VRTX) United States $47.401B 107.84
Regeneron Pharmaceuticals (REGN) United States $43.120B 24.24
Alexion Pharmaceuticals (ALXN) United States $28.735B 21.60
BioMarin Pharmaceutical (BMRN) United States $18.837B 0.00
Incyte (INCY) United States $13.826B 464.57
Seattle Genetics (SGEN) United States $11.846B 0.00
Sarepta Therapeutics (SRPT) United States $9.434B 0.00
Alnylam Pharmaceuticals (ALNY) United States $8.180B 0.00
Exact Sciences (EXAS) United States $8.108B 0.00
QIAGEN (QGEN) Netherlands $8.064B 26.37
Bio-Techne Corp (TECH) United States $6.914B 46.24
Bluebird Bio (BLUE) United States $6.866B 0.00
BeiGene (BGNE) Cayman Islands $6.789B 0.00
Alkermes (ALKS) Ireland $6.419B 0.00
Amarin (AMRN) Ireland $6.031B 0.00
Galapagos (GLPG) Belgium $5.305B 0.00
Exelixis (EXEL) United States $5.070B 16.51
Ligand Pharmaceuticals (LGND) United States $4.284B 37.95
Immunomedics (IMMU) United States $4.176B 0.00
GUARDANT HEALTH (GH) United States $3.403B 0.00
Myriad Genetics (MYGN) United States $3.321B 35.28
Ultragenyx Pharmaceutical (RARE) United States $3.314B 0.00
Horizon Pharma Public (HZNP) Ireland $3.213B 18.19
Array BioPharma (ARRY) United States $3.207B 0.00
Emergent Biosolutions (EBS) United States $3.150B 25.09
Blueprint Medicines (BPMC) United States $3.099B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.096B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.049B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.859B 0.00
Ascendis Pharma (ASND) Denmark $2.720B 0.00
Halozyme Therapeutics (HALO) United States $2.587B 34.48
Repligen (RGEN) United States $2.518B 84.53
ARGENX SE-ADR (ARGX) Netherlands $2.518B 0.00
Genomic Health (GHDX) United States $2.450B 136.64
Amicus Therapeutics (FOLD) United States $2.428B 0.00
China Biologic Products (CBPO) China $2.411B 16.57
Acceleron Pharma (XLRN) United States $2.374B 0.00
MyoKardia (MYOK) United States $2.302B 0.00
Medicines (MDCO) United States $2.049B 0.00
Akcea Therapeutics (AKCA) United States $2.038B 0.00
Arena Pharmaceuticals (ARNA) United States $2.031B 0.00
REGENXBIO (RGNX) United States $1.997B 31.38
AnaptysBio (ANAB) United States $1.956B 0.00
Cambrex (CBM) United States $1.946B 15.60
Spark Therapeutics (ONCE) United States $1.907B 0.00
CRISPR THERAPTC (CRSP) Switzerland $1.875B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.868B 0.00
Global Blood Therapeutics (GBT) United States $1.866B 0.00
Reata Pharmaceuticals (RETA) United States $1.850B 0.00
Atara Biotherapeutics (ATRA) United States $1.730B 0.00
Aimmune Therapeutics (AIMT) United States $1.689B 0.00
Allakos (ALLK) United States $1.689B 0.00
Puma Biotechnology (PBYI) United States $1.668B 0.00
Clovis Oncology (CLVS) United States $1.656B 0.00
Denali Therapeutics (DNLI) United States $1.643B 0.00
Innoviva (INVA) United States $1.567B 10.06
G1 THERAPEUTICS (GTHX) United States $1.564B 0.00
Myovant Sciences (MYOV) United Kingdom $1.504B 0.00
Sangamo Therapeutics (SGMO) United States $1.489B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.447B 0.00
WAVE Life Sciences (WVE) Singapore $1.428B 0.00
Editas Medicine (EDIT) United States $1.409B 0.00
Rubius Therapeutics (RUBY) United States $1.405B 0.00
Mirati Therapeutics (MRTX) United States $1.365B 0.00
Insmed (INSM) United States $1.354B 0.00
IMMURON LTD (IMRN) Australia $1.287B 0.00
Solid Biosciences (SLDB) United States $1.255B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.191B 2273.00
Momenta Pharmaceuticals (MNTA) United States $1.183B 0.00
Cellectis (CLLS) France $1.163B 0.00
NeoGenomics (NEO) United States $1.149B 201.14
DBV Technologies (DBVT) France $1.108B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.090B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.090B 0.00
UniQure (QURE) Netherlands $1.080B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.079B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.072B 0.00
Intellia Therapeutics (NTLA) United States $1.062B 0.00
Intra-Cellular Therapies (ITCI) United States $1.060B 0.00
Audentes Therapeutics (BOLD) United States $1.055B 0.00
Retrophin (RTRX) United States $1.053B 0.00
Lion Biotechnologies (IOVA) United States $1.040B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $0.987B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.970B 0.00
Athenex (ATNX) United States $0.941B 0.00
Apellis Pharmaceuticals (APLS) United States $0.939B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.938B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.936B 0.00
Revance Therapeutics (RVNC) United States $0.915B 0.00
Acorda Therapeutics (ACOR) United States $0.911B 19.00
Aptinyx (APTX) United States $0.908B 0.00
Viking Therapeutics (VKTX) United States $0.901B 0.00
Coherus BioSciences (CHRS) United States $0.881B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.851B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.806B 0.00
Cara Therapeutics (CARA) United States $0.800B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.791B 0.00
InflaRx (IFRX) Germany $0.787B 0.00
Novavax (NVAX) United States $0.777B 0.00
Fate Therapeutics (FATE) United States $0.774B 0.00
CytomX Therapeutics (CTMX) United States $0.763B 0.00
Heska (HSKA) United States $0.758B 65.25
Dynavax Technologies (DVAX) United States $0.736B 0.00
AVROBIO (AVRO) United States $0.731B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.713B 0.00
Epizyme (EPZM) United States $0.699B 0.00
Mesoblast (MESO) Australia $0.684B 0.00
ANI Pharmaceuticals (ANIP) United States $0.668B 13.22
ObsEva SA (OBSV) Switzerland $0.637B 0.00
AC Immune SA (ACIU) Switzerland $0.631B 0.00
UROGEN PHARMA (URGN) Israel $0.615B 0.00
Kura Oncology (KURA) United States $0.604B 0.00
Anika Therapeutics (ANIK) United States $0.604B 25.40
MiMedx (MDXG) United States $0.588B 25.24
NuCana Sponsored ADR (NCNA) United Kingdom $0.566B 0.00
Arcus Biosciences (RCUS) United States $0.552B 0.00
Principia Biopharma (PRNB) United States $0.546B 0.00
Vericel (VCEL) United States $0.540B 0.00
RA PHARMCTL INC (RARX) United States $0.531B 0.00
UNITY Biotechnology (UBX) $0.522B 0.00
Prothena (PRTA) Ireland $0.519B 0.00
Five Prime Therapeutics (FPRX) United States $0.512B 0.00
Inovio Pharmaceuticals (INO) United States $0.507B 0.00
ARVINAS INC (ARVN) United States $0.506B 0.00
Aduro Biotech (ADRO) United States $0.494B 0.00
Scholar Rock Holding (SRRK) United States $0.483B 0.00
Senesco Technologies (ELOX) United States $0.483B 0.00
Stemline Therapeutics (STML) United States $0.483B 0.00
Abeona Therapeutics (ABEO) United States $0.481B 0.00
MediciNova (MNOV) United States $0.471B 0.00
Cytokineticsorporated (CYTK) United States $0.456B 0.00
Kezar Life Sciences (KZR) United States $0.447B 0.00
Verastem (VSTM) United States $0.444B 0.00
Kindred Biosciences (KIN) United States $0.443B 0.00
Zealand Pharma (ZEAL) Denmark $0.440B 0.00
Liquidia Technologies (LQDA) United States $0.432B 0.00
Zymeworks (ZYME) Canada $0.431B 0.00
BeyondSpring (BYSI) United States $0.431B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.430B 0.00
Sorrento Therapeutics (SRNE) United States $0.427B 73.20
Replimune (REPL) United States $0.423B 0.00
Sinovac Biotech (SVA) China $0.416B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.400B 0.00
UROVANT SCIENCS (UROV) United States $0.387B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.382B 0.00
Merus (MRUS) Netherlands $0.382B 0.00
GRITSTONE ONCLG (GRTS) United States $0.374B 0.00
PDL BioPharma (PDLI) United States $0.374B 5.24
MeiraGTx Holdings (MGTX) United States $0.365B 0.00
Osiris Therapeutics (OSIR) United States $0.362B 0.00
KODIAK SCIENCES (KOD) United States $0.362B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.356B 0.00
ResTORbio (TORC) United States $0.355B 0.00
Albireo Pharma (ALBO) United States $0.346B 0.00
Selecta Biosciences (SELB) United States $0.343B 0.00
Eidos Therapeutics (EIDX) United States $0.340B 0.00
SUTRO BIOPHARMA (STRO) United States $0.329B 0.00
Magenta Therapeutics (MGTA) United States $0.328B 0.00
Kala Pharmaceuticals (KALA) United States $0.328B 0.00
Kadmon Holdings (KDMN) United States $0.325B 0.00
Geron (GERN) United States $0.323B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.321B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.318B 0.00
Adverum Biotechnologies (ADVM) United States $0.316B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.313B 0.00
Evelo Biosciences (EVLO) United States $0.311B 0.00
Axovant Sciences (AXON) United Kingdom $0.309B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.308B 0.00
Cellular Biomedicine (CBMG) United States $0.296B 0.00
MannKind (MNKD) United States $0.295B 0.00
Unum Therapeutics (UMRX) United States $0.295B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.294B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.293B 0.00
Athersys (ATHX) United States $0.292B 0.00
Seres Therapeutics (MCRB) United States $0.278B 0.00
BioTime (BTX) United States $0.274B 0.00
TOCAGEN INC (TOCA) United States $0.263B 0.00
Celcuity (CELC) United States $0.262B 0.00
Arbutus Biopharma (ABUS) Canada $0.261B 0.00
Celyad SA (CYAD) Belgium $0.261B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.252B 0.00
Synlogic (SYBX) United States $0.251B 0.00
Syros Pharmaceuticals (SYRS) United States $0.250B 0.00
ADMA Biologics Inc (ADMA) United States $0.249B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.245B 0.00
Kamada (KMDA) Israel $0.240B 18.66
ASLAN Pharmaceuticals (ASLN) Singapore $0.239B 0.00
Strongbridge Biopharma (SBBP) United States $0.237B 0.00
Idera Pharmaceuticals (IDRA) United States $0.236B 0.00
Krystal Biotech (KRYS) United States $0.235B 0.00
Agenus (AGEN) United States $0.233B 0.00
NantKwest (NK) United States $0.229B 0.00
BioDelivery Sciences (BDSI) United States $0.223B 0.00
Protagonist Therapeutics (PTGX) United States $0.221B 0.00
Allena Pharmaceuticals (ALNA) United States $0.220B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.211B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.209B 0.00
ChromaDex (CDXC) United States $0.206B 0.00
Mersana Therapeutics (MRSN) United States $0.197B 0.00
Palatin Technologies (PTN) United States $0.191B 7.89
Spring Bank Pharmaceuticals (SBPH) United States $0.190B 0.00
CorMedix Inc (CRMD) United States $0.188B 0.00
Compugen (CGEN) Israel $0.188B 0.00
Cerecor (CERC) United States $0.185B 18.92
Enzo Biochem (ENZ) United States $0.178B 0.00
Clearside Biomedical (CLSD) United States $0.174B 0.00
Constellation Pharmaceuticals (CNST) United States $0.174B 0.00
Cohbar (CWBR) United States $0.173B 0.00
Intec Pharma (NTEC) Israel $0.171B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.170B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.166B 0.00
OVID THERAPEUTC (OVID) United States $0.163B 0.00
Signal Genetics (MGEN) United States $0.162B 0.00
PSivida (EYPT) United States $0.162B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.158B 0.00
Spero Therapeutics (SPRO) United States $0.156B 0.00
VBI Vaccines (VBIV) United States $0.144B 0.00
Cue Biopharma (CUE) United States $0.143B 0.00
Menlo Therapeutics (MNLO) United States $0.142B 0.00
Pfenex (PFNX) United States $0.140B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.140B 0.00
Monster Digital (INNT) United States $0.137B 0.00
Pluristem Therapeutics (PSTI) Israel $0.136B 0.00
XOMA (XOMA) United States $0.134B 14.19
Eleven Biotherapeutics (SESN) United States $0.132B 0.00
Mustang Bio (MBIO) United States $0.130B 0.00
XBiotech (XBIT) United States $0.130B 0.00
VTv Therapeutics (VTVT) United States $0.126B 0.00
Organovo Holdings (ONVO) United States $0.124B 0.00
ITUS (ANIX) United States $0.123B 0.00
Catalyst Biosciences (CBIO) United States $0.122B 0.00
Motif Bio Plc (MTFB) United States $0.120B 0.00
Provention Bio (PRVB) United States $0.119B 0.00
Applied Genetic Technologies (AGTC) United States $0.117B 0.00
Tapimmune (TPIV) United States $0.114B 0.00
Anavex Life Sciences (AVXL) United States $0.112B 0.00
Cidara Therapeutics (CDTX) United States $0.111B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.106B 0.00
Cel-Sci (CVM) United States $0.104B 0.00
Axsome Therapeutics (AXSM) United States $0.103B 0.00
BioXcel Therapeutics (BTAI) United States $0.103B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.102B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.101B 0.00
Neothetics (EVFM) United States $0.101B 0.00
Aptevo Therapeutics (APVO) United States $0.099B 0.00
VolitionRX (VNRX) Singapore $0.097B 0.00
Orgenesis (ORGS) United States $0.095B 0.00
ScPharmaceuticals (SCPH) United States $0.095B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.094B 0.00
Leap Therapeutics (LPTX) United States $0.094B 0.00
Chiasma (CHMA) United States $0.091B 0.00
Prima BioMed (IMMP) Australia $0.090B 0.00
Checkpoint Therapeutics (CKPT) United States $0.090B 0.00
Cocrystal Pharma (COCP) United States $0.086B 0.00
Ophthotech (OPHT) United States $0.085B 0.55
Protalix BioTherapeutics (PLX) Israel $0.085B 0.00
OncoSec Medical (ONCS) United States $0.083B 0.00
NewLink Genetics (NLNK) United States $0.083B 0.00
Aptose Biosciences (APTO) Canada $0.080B 0.00
Sophiris Bio (SPHS) United States $0.076B 0.00
Alcobra (ARCT) United States $0.075B 0.00
Curis (CRIS) United States $0.075B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.074B 0.00
Celldex Therapeutics (CLDX) United States $0.072B 0.00
Vaccinex (VCNX) United States $0.072B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.071B 0.00
BIONANO GENOMIC (BNGO) United States $0.070B 0.00
Proteostasis Therapeutics (PTI) United States $0.069B 0.00
Evogene (EVGN) Israel $0.069B 0.00
Trevena (TRVN) United States $0.069B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.067B 0.00
Alimera Sciences (ALIM) United States $0.067B 0.00
Oncobiologics (ONS) United States $0.064B 0.00
Entera Bio (ENTX) Israel $0.064B 0.00
Fortress Biotech (FBIO) United States $0.062B 0.00
Bellerophon Therapeutics (BLPH) United States $0.059B 0.00
Asterias Biotherapeutics (AST) United States $0.058B 0.00
Oncolytics Biotech (ONCY) Canada $0.056B 0.00
VistaGen Therapeutics (VTGN) United States $0.051B 0.00
Vascular Biogenics (VBLT) Israel $0.051B 0.00
VIVUS (VVUS) United States $0.048B 0.00
Zosano Pharma (ZSAN) United States $0.048B 0.00
TRACON Pharmaceuticals (TCON) United States $0.048B 0.00
Celsion (CLSN) United States $0.048B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.045B 0.00
AZURRX BIOPHARM (AZRX) United States $0.045B 0.00
Caladrius Biosciences (CLBS) United States $0.044B 0.00
GTx (GTXI) United States $0.043B 0.00
Eyenovia (EYEN) United States $0.040B 0.00
AquaBounty Technologies (AQB) United States $0.040B 0.00
Galena Biopharma (SLS) United States $0.040B 0.00
Aileron Therapeutics (ALRN) United States $0.038B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.037B 0.00
Advaxis (ADXS) United States $0.036B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.036B 0.00
BioPharmX (BPMX) United States $0.035B 0.00
Moleculin Biotech (MBRX) United States $0.034B 0.00
Proteon Therapeutics (PRTO) United States $0.032B 0.00
CytRx (CYTR) United States $0.029B 0.00
Cellect Biotechnology (APOP) Israel $0.028B 0.00
Vical (VICL) United States $0.027B 0.00
GENPREX INC (GNPX) United States $0.027B 0.00
OvaScience (OVAS) United States $0.027B 0.00
Benitec Biopharma (BNTC) Australia $0.026B 0.00
Edge Therapeutics (EDGE) United States $0.026B 0.00
AEterna Zentaris (AEZS) United States $0.025B 51.00
Gemphire Therapeutics (GEMP) United States $0.023B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.023B 0.00
Arsanis (ASNS) United States $0.022B 0.00
Histogenics (HSGX) United States $0.021B 0.00
ATyr Pharma (LIFE) United States $0.021B 0.00
Novelion Therapeutics (NVLN) Canada $0.021B 0.00
Genetic Technologies (GENE) Australia $0.020B 0.00
RestorGenex (DFFN) United States $0.020B 0.00
Cleveland BioLabs (CBLI) United States $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
TrovaGene (TROV) United States $0.019B 0.00
Soligenix (SNGX) United States $0.018B 0.00
Prana Biotechnology (PRAN) Australia $0.018B 0.00
Therapix Biosciences (TRPX) Israel $0.017B 6.49
Adial Pharmaceuticals (ADIL) United States $0.017B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.017B 0.00
Pulmatrix (PULM) United States $0.016B 0.00
IBio (IBIO) United States $0.015B 0.00
Novogen (KZIA) Australia $0.015B 0.00
Neuralstem (CUR) United States $0.015B 0.00
Vital Therapies (VTL) United States $0.013B 0.00
Flex Pharma (FLKS) United States $0.012B 0.00
Cerulean Pharma (DARE) United States $0.012B 0.00
Alliqua BioMedical (ALQA) United States $0.010B 0.00
Hemispherx BioPharma (HEB) United States $0.010B 0.00
ARCA Biopharma (ABIO) United States $0.009B 0.00
MYOS RENS Technology (MYOS) United States $0.008B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.008B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
Stellar Biotechnologies (SBOT) United States $0.007B 0.00
Synthetic Biologics (SYN) United States $0.006B 0.00
AmpliPhi Biosciences (APHB) United States $0.006B 0.00
Titan Pharmaceuticals (TTNP) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.003B 0.00
Aytu Bioscience (AYTU) United States $0.002B 0.00
Bio-Rad Laboratories (BIO.B) United States $0.000B 0.00
Y-MABS THERAPTC (YMAB) United States $0.000B 0.00